The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

ON IVA's 100 list: Hair analysis to find cancer at an early stage

Stock photo of hair strands. Computerized image.
According to Emma Hammarlund's research hypothesis, chemical imprints in hair strands can give an indication of cancer at an early stage. Photo: iStock.

Researcher Emma Hammarlund realized that geological measurement methods can also be used for medical purposes. With a simple hair sample, she hopes to find cancer at an early stage. First in the study are prostate cancer and breast cancer. Now her project has been selected for the Royal Swedish Academy of Engineering Sciences' (IVA) 100 list. The list also includes eight other research projects from Lund University, two of which at the Lund Stem Cell Center.

IVA's list highlights current research that can benefit society. The purpose is, among other things, to raise the ideas so that they can arouse interest in - and gain traction from - more collaborative actors. Emma Hammarlund sees precisely that part as important for the project. Although the connection to medical research was not immediately clear to the medical research colleagues, it was Emma Hammarlund's background as a geologist that gave birth to the idea: the progress of a cancer can be tracked via hair analysis. Nowadays, Emma Hammarlund is also an associate professor in medicine at Lund University, with a focus on developmental biology.

Cancer cells' higher metabolism means that various elements are metabolized faster than in other cells. According to Emma Hammarlund's hypothesis, this will appear as chemical imprints in the hairs. When the elemental composition of stable isotopes is examined in the hairs, traces of "voracious" cancer cells are revealed. A number of elements in the hair will be investigated within the project. Several elements have different types of themselves, so-called isotopes. The chemical composition is almost identical, but between different isotopes the number of neutrons in the atomic nucleus differs slightly. 

Photo of Emma Hammarlund in the lab.
Emma Hammarlund in the lab. Photo: Auraya Manaprasertsak

The research aims to see how hungry cancer cells use even harder-to-reach isotopes, in contrast to how calmer cells behave. This mechanism is studied by mapping chemical changes directly in the tissue of mice, but also directly in hair analyses. To help them, the research team also uses AI algorithms.

Having already tested the idea both on tissue from mice and hair from humans, Emma Hammarlund still strongly believes in her hypothesis.

"It is too early to change gears, but the prototype looks good," says Emma Hammarlund.

The idea is to be able to design a reliable hair analysis for a variety of cancers. Emma Hammarlund's long-term hope is that the analysis will be able to support other methods of finding cancer early - and in time for it to be cured. 

"A cancer that is detected early reduces mortality and suffering - and saves society a lot of money."

So far, hair from men both with and without localized prostate cancer (cancer that has not spread) has been collected, thanks to the involvement of oncology professor Ken Pienta at Johns Hopkins in the US in the project. Other researchers in the project are Lund University colleague and bioinformatician Kazi Uddin, and chemist Per Malmberg at Chalmers. Emma Hammarlund would also like to mention two other important players: Anders Bjartell and Emma Niméus, who both do research at Lund University and work clinically at Skåne University Hospital. It is their team that is currently helping to collect hair from Swedish patients with prostate and breast cancer. Hair from healthy women and men, for the control group, has been collected from hairdressers in Skåne and Stockholm.

"The performance of the first hair test will later be tested in a clinical study. We will start doing that as soon as the next algorithm is fully developed," says Emma Hammarlund.

Funders for the study are the Cancerfonden and the Sjöberg Foundation.

Bioengineering Mini-Bones for Personalized Cancer Therapies

Another project from Lund Stem Cell Center has also been recognized on IVA’s 100 List. Led by Paul Bourgine, Associate Senior Lecturer at Lund University's Wallenberg Centre for Molecular Medicine and Lund Stem Cell Center, alongside researchers Dimitra Zacharaki and Alejandro Garcia Garcia, the team is pioneering the development of OssiGel. This innovative technology creates personalized miniature human bones to study and treat bone-related cancers.

Recognized with an ERC Proof of Concept grant in 2022, OssiGel offers a new platform for precise drug testing and personalized therapies, advancing research on cancers that originate in or spread to the bone.

To learn more, read: "Miniature bones as a research model for cancer"

Emma Hammarlund

Contact

Emma Hammarlund is a geobiologist and associate professor in medicine, with a focus on developmental biology at Lund University. She heads the Evolution of Stemness Control and Multicellularity Research Group which is affiliated with the Lund University Cancer Centre, EpiHealth, and the Lund Stem Cell Center.

Profile in the Lund University Research Portal

More about the Evolution of Stemness Control and Multicellularity Research Group

About IVA's 100 list

The Royal Swedish Academy of Engineering, IVA's, annual 100 list "shines the light on current research with the potential to create benefit through commercialization, business and method development or societal impact". 

This year, nine projects from Lund University were recognized on the list. Below is a quick overview of the projects from Lund University that made the list for 2024:

LU project on IVA's 100 list in 2024